FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
2 reports, 1 independent
Updated Jun 28
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.First confirmed screwworm case in Texas livestock; industry thanks FDA for preparation.1 source
- FDA grants combination clearance for Elanco's Experior.
Keep exploring
The entities involved
Related events
- FDA approval enables commercial availability for a product associated with Indianapolis.
- FDA granted 510(k) clearance for combined technologies for Solventum.
- Unregulated products are bypassing official government approval processes.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- Providence Medical Technology, Inc. received 510(k) clearance from the FDA and plans to showcase its system at the Henry B. González Convention Center.
Coverage
Newest first; wire copies grouped- hpj.com
- Unknown outlet